Skip to content
Low Dose GLP-1Providers

Provider review

AbundRX review

Its cards and its FAQ state the same two prices, and they agree.

Neither figure carries a billing period, so you know two numbers and not what either one buys.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.

Price as published

AbundRX

$99 semaglutide and $149 tirzepatide, no period stated

Vs median
Not comparable — no per-month rate is published — the verified string carries no monthly figure
Market
$59–$1300/mo across 242 of 373
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

In one paragraph

The verdict

The reason to note this one is consistency. Its two figures appear in the product cards and again in the FAQ, in the same words, agreeing exactly. That sounds like the minimum and it is not, because several sellers we have looked at contradict themselves between precisely those two places on the same page. What is missing here is the denominator. Neither figure carries a billing period — not a month, not a supply length, not a course — so you come away knowing two numbers and not knowing what either one buys. A separately advertised premium access unlock uses the same ninety-nine dollars for something else again, which makes the front page harder to read rather than easier. The care descriptions are hedged throughout in the language of what a treatment may do, and no milligram appears anywhere.

Visit AbundRX

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You want the price in the card to match the price in the FAQ
  • You want both figures visible without an intake
  • You will ask what period the figure covers before paying

Look elsewhere if

  • You want to know what the price actually buys. No period is stated
  • You are confused by one number being used for two different things
  • You want a dose behind the number

What it actually costs

Price as published

Semaglutide-based care "Starting at $99" and tirzepatide-based care "Starting at $149", each stated on a product card and then repeated in the FAQ in the same words — "Programs begin at $99 for semaglutide-based care and $149 for tirzepatide-based care" · ★ THAT AGREEMENT IS WORTH NAMING, because several sellers here publish one figure in a card and a different one in an FAQ on the same page; this one says the same thing twice · neither figure carries a billing period — no month, no supply length, no course — so what the $99 buys is not established anywhere · a "$99 Premium Access" unlock is advertised separately, which uses the same number for a different thing · no milligram is published

Vs median
Not comparable — no per-month rate is published — the verified string carries no monthly figure
Market
$59–$1300/mo is the full published spread in our ranking
Structure
Standard plan, self-directed low dose

No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.

152 of the 373 programs we track price a small dose this way. ★ Its two figures appear in the cards and again in the FAQ and they agree exactly, which is worth naming because several sellers here contradict themselves between those two places. But neither figure carries a billing period, so a reader knows two numbers and not what either buys, and a separate access unlock reuses one of them for something else. No low-dose product and no dose published.

Visit AbundRX

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Included in the price
Dietitian
Not included
Labs
Not required
Pricing
Varies by dose, plan or tier
Price last updated
August 2026

What it does well

  • Its two prices are stated twice, in the cards and the FAQ, and they agree.
  • Both figures are visible without an intake.
  • Free shipping is included and stated on the same line as the price.

Pharmacy, labs and oversight

AbundRX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Transparency check

1 of 4 published openly

What AbundRX publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
Not published
A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
Not published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
Not published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
None on file

How the program works

The reason to note this one is consistency. Its two figures appear in the product cards and again in the FAQ, in the same words, agreeing exactly — which sounds like the minimum and is not, because several sellers on this page contradict themselves between those two places. What is missing is the denominator. Neither figure carries a billing period: not a month, not a supply length, not a course, so a reader knows two numbers and not what either one buys. A separately advertised premium access unlock uses the same ninety-nine dollars for something else again, which makes the front page harder to read rather than easier. The care descriptions are hedged throughout in the language of what a treatment may do, and no milligram appears anywhere.

The honest cons

Neither figure states a billing period, so what it buys is unknown.
  • The same number is used for a separate premium access unlock.
  • No milligram appears against either figure.
Visit AbundRX

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

AbundRX is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Where this sits

#328 of 373

Ordered with the companies that pay us first, and AbundRX is not one of them. A disclosed partition, not a score.

Compare all 373 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Visit AbundRX

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

RxSpan MD

From $194/mo

Vs median
$25/mo above the $169 median
Market
$59–$1300/mo across 242 of 373
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the RxSpan MD review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.